Angiogenesis and lymphangiogenesis - Implications for corneal immunity

Seminars in Ophthalmology

Volumn 21, Issue 1, 2006, Pages 19-22

  Dana, M ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; CHEMOKINE; CHEMOKINE RECEPTOR CXCR1; COLLAGENASE; CYTOKINE; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; IMMUNOGLOBULIN; INTEGRIN; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 1; INTERLEUKIN 8; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MONOCYTE CHEMOTACTIC PROTEIN 1; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN; VASCULOTROPIN C; VASCULOTROPIN D; VASCULOTROPIN RECEPTOR 3; VERY LATE ACTIVATION ANTIGEN 1;

ALLOIMMUNITY; ANGIOGENESIS; ANTIGEN PRESENTING CELL; BLOOD VESSEL PERMEABILITY; BONE MARROW CELL; CELL ACTIVATION; CELL ADHESION; CORNEA; CORNEA TRANSPLANTATION; GRAFT SURVIVAL; HISTOCOMPATIBILITY; IMMUNITY; IMMUNOCOMPETENT CELL; IMMUNOREGULATION; IMMUNOSUPPRESSIVE TREATMENT; INNATE IMMUNITY; LYMPHANGIOGENESIS; LYMPHATIC SYSTEM; LYMPHOCYTE; MOLECULAR DYNAMICS; OCULAR BLOOD VESSEL; PRIORITY JOURNAL; REVIEW; VASCULAR ENDOTHELIUM; ANIMAL; CORNEA NEOVASCULARIZATION; HUMAN; IMMUNOLOGY; VASCULARIZATION;

ANIMALS; CORNEA; CORNEAL NEOVASCULARIZATION; HUMANS; IMMUNITY, NATURAL; LYMPHANGIOGENESIS;

EID: 33646949958     PISSN: 08820538     EISSN: 17445205     Source Type: Journal    
DOI: 10.1080/08820530500509358     Document Type: Review

References (24)

1. Chang LK, Garcia-Cardena G, Farnebo F, Fannon M, Chen EJ, Butterfield C, Moses MA, Mulligan RC, Folkman J, Kaipainen A. Dose-dependent response of FGF-2 for lymphangiogenesis. Proc Natl Acad Sci USA 2004; 101:11658-63.
2. Chen L, Hamrah P, Cursiefen C, Zhang Q, Pytowski B, Streilein JW, Dana R. Vascular endothelial growth factor receptor-3 (VEGFR-3) mediates dendritic cell migration and induction of immunity to corneal transplants. Nature Med 2004; 10: 813-15.
3. Cursiefen C, Chen L, Dana MR, Streilein JW. Corneal lymphangiogenesis: evidence, mechanisms, and implications for corneal transplant immunology. Cornea 2003; 22:273-81.
4. Cursiefen C, Chen L, Jackson D, Dana MR, Streilein JW. Inhibition of hemangiogenesis and lymphangiogenesis after normal-risk corneal transplantation by neutralizing VEGF promotes graft survival. Investigative Ophthalmology and Vis Sci 2004 (a); 45:2666-73.
5. Cursiefen C, Chen L, Borges L, Jackson D, Cao J, Radziejewski C, D'Amore P, Dana MR, Weigand SJ, Streilein JW. VEGF-A stimulates lymph- and hemangiogenesis in inflammatory neovascularization via macrophage recruitment. J Clin Invest 2004 (b); 113:1040-50.
6. Dana MR, Schaumberg DA, Kowal VA, Goren MB, Rapuano CJ, Cohen EJ, Laibson PR. Predictors of corneal neovascularization after penetrating keratoplasty. Cornea 1995; 14:604-9.
7. Dana MR, Streilein JW. Corneal neovascularization and ocular immune privilege. Invest Ophthalmol Vis Sci 1996; 37:2485-94.
8. Dana MR, Yamada J, Streilein JW. Topical interleukin-1 receptor antagonist promotes corneal transplant survival. Transplantation 1997; 63:1501-7.
9. Dana MR, Zhu S, Yamada J. Topical modulation of interleukin-1 activity in corneal inflammatory neovascularization. Cornea 1998; 17:403-9.
10. Dana MR, Qian Y, Hamrah P. Emerging concepts in the immunopathogenesis of microbial keratitis, peripheral ulcerative keratitis, and corneal transplant rejection. Cornea 2000; 19:625-43.
11. Dana MR. Corneal antigen-presenting cells: Diversity, plasticity, and disguise. The Cogan Lecture. Invest Ophthalmol Vis Sci 2004; 45:722-7.
12. Dekaris I, Zhu S, Dana MR. Tumor nercrosis factor-alpha regulates corneal Langerhans cell migration. J Immunol 1999; 162:4235-9.
13. Hamrah P, Huq S, Liu Y, Zhang Q, Dana MR. Corneal immunity is mediated by heterogeneous population of antigen-presenting cells. J Leuk Bio 2003 (a); 4:172-6.
14. Hamrah P, Liu Y, Qiang Z, Dana MR. Alterations in corneal stromal dendritic cell phenotype and distribution in inflammation. Arch Ophthalmol 2003 (b); 121:1132-40.
15. Hamrah P, Chen L, Zhang Q, Dana MR. Novel expression of vascular endothelial growth factor receptor (VEGFR)-3 and VEGF-c on corneal dendritic cells. Am J Path 2003 (c); 163:57-68.
16. Huq S, Liu Y, Benichou G, Dana MR. Relevance of the direct pathway of sensitization in corneal transplantation is dictated by the graft bed microenvironment. J Immunol 2004; 173:4464-9.
17. Liu Y, Hamrah P, Zhang Q, Taylor AW, Dana MR. Draining lymph nodes of corneal transplant hosts exhibit evidence for donor MHC class II-positive dendritic cells derived from MHC class II-negative grafts. J Exp Medicine 2002; 195:259-68.
18. Qian Y, Dana MR. Molecular mechanisms of immunity in corneal allotransplantation and xenotransplantation: current status of basic research and possible future directions in clinical applications. Exp Rev Mol Med 2001; 3:1-21.
19. Rosenkilde MM, Schwartz TW. The chemokine system - a major regulator of angiogenesis in health and disease. APMIS 2004; 112:481-95.
20. Yamada J, Dana MR, Zhu S, Alard P, Streilein JW. Suppression of allosensitization in corneal transplantation by modulation of IL-1 activity. Arch Ophthalmol 1998; 116:1351-7.
21. Yamagami S, Dana MR. The critical role of draining lymph nodes in corneal alloimmunization and graft rejection.Invest Ophthalmol Vis Sci 2001; 42:1293-8.
22. Yamagami S, Dana MR, Tsuru T. Draining lymph nodes play an essential role in alloimmunity generated in response to high-risk corneal transplantation. Cornea 2002; 21:405-9.
23. Zheng M, Schwarz MA, Lee S, Kumaraguru U, Rouse BT. Control of stromal keratitis by inhibition of neovascularization. Am J Pathol 2001; 159:1021-9.
24. Zhu S, Dana MR. Expression of cell adhesion molecules on limbal and neovascular endothelium in corneal inflammatory neovascularization. Invest Ophthalmol Vis Sci 1999; 40:1427-34.